These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma. Fuks Z; Rizel S; Biran S J Clin Oncol; 1988 Mar; 6(3):509-16. PubMed ID: 3127551 [TBL] [Abstract][Full Text] [Related]
3. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration. Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study. Randall ME; Barrett RJ; Spirtos NM; Chalas E; Homesley HD; Lentz SL; Hanna M Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):139-47. PubMed ID: 12118543 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma. Barlow JJ; Lele SB Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408 [TBL] [Abstract][Full Text] [Related]
6. Advanced minimal residual ovarian carcinoma: abdominopelvic irradiation following combination chemotherapy. Hainsworth JD; Malcolm A; Johnson DH; Burnett LS; Jones HW; Greco FA Obstet Gynecol; 1983 May; 61(5):619-23. PubMed ID: 6403897 [TBL] [Abstract][Full Text] [Related]
7. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878. Wadler S; Yeap B; Vogl S; Carbone P Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766 [TBL] [Abstract][Full Text] [Related]
8. Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinoma. Baker TR; Piver MS; Hempling RE Cancer; 1994 Jul; 74(2):656-63. PubMed ID: 8033045 [TBL] [Abstract][Full Text] [Related]
9. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma. Wils J; Blijham G; Naus A; Belder C; Boschma F; Bron H; Ceelen T; Eekhout A; von Erp J; Geelen P J Clin Oncol; 1986 Jul; 4(7):1068-73. PubMed ID: 3723166 [TBL] [Abstract][Full Text] [Related]
10. The sequential multiple modality treatment of ovarian cancer. Dembo AJ Radiother Oncol; 1985 Apr; 3(3):187-92. PubMed ID: 3923573 [No Abstract] [Full Text] [Related]
12. Sequential multi-agent chemotherapy and whole abdominal irradiation for stage III ovarian carcinoma. Rosen EM; Goldberg ID; Rose C; Come S; Goldstein M; Simon L; Botnick LE Radiother Oncol; 1986 Nov; 7(3):223-31. PubMed ID: 3809585 [TBL] [Abstract][Full Text] [Related]
13. [Importance of clinically prognostic factors in the treatment of advanced ovarian carcinoma]. Albrecht M; Goepel E; Simon WE; Trams G Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):482-7. PubMed ID: 2993094 [TBL] [Abstract][Full Text] [Related]
14. The treatment of advanced stage ovarian carcinoma with a combination of chemotherapy, radiotherapy, and radiosensitizer: report of a pilot study from the National Cancer Institute. Lichter AS; Ozols RF; Myers CC; Ostechega Y; Young RC Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1225-31. PubMed ID: 3112047 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of 63 advanced ovarian carcinomas]. Liu LY; Hong WJ; Hou YJ; Yao ZH; Wu AR; Li L Zhonghua Zhong Liu Za Zhi; 1987 Sep; 9(5):375-8. PubMed ID: 3452529 [TBL] [Abstract][Full Text] [Related]
17. Management of recurrent ovarian carcinoma. Ang PT; Kavanagh J Am J Clin Oncol; 1989 Jun; 12(3):269-72. PubMed ID: 2543208 [No Abstract] [Full Text] [Related]
18. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. Piver MS; Lele SB; Marchetti DL; Baker TR; Tsukada Y; Emrich LJ J Clin Oncol; 1988 Jun; 6(6):983-9. PubMed ID: 3373267 [TBL] [Abstract][Full Text] [Related]